LISATA THERAPEUTICS, INC. — Director's Dealing 2016

Nov 10, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Caladrius Biosciences, Inc. (CLBS)
CIK: 0000320017
Period of Report: 2016-10-25

Reporting Person: LOSORDO DOUGLAS W (See Remarks)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-10-25	Common Stock	F	176	$4.12	Disposed	14851	Direct

Footnotes

F1: Includes 4,271 shares of unvested restricted stock.